According to GlobalData, MISAGO is one of 32 product lines sold in the US peripheral vascular stents market; these product lines are sold by 11 different manufacturers. The average selling price for MISAGO decreased in hospitals, decreased in health systems, and increased outside of hospital facilities in 2022. The price of the MISAGO device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Peripheral Vascular Stents - Terumo Corp - MISAGO

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Terumo apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Terumo overview

Terumo Corp (Terumo) manufactures and markets medical care products including hospital and medical products and equipment. The company’s major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, medical electronic, peritoneal dialysis, and digital thermometers. Its systems find applications in therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing it for addressing the transfusion requirement of patients. The company operates through subsidiaries and associate companies in Japan, China, Europe, North America, South America, Asia Pacific, the Middle East and Africa. Terumo is headquartered in Shibuya-ku Tokyo, Japan.

For a complete picture of MISAGO, Peripheral Vascular Stents pricing in the US, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.